StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $21.10 | $22.00 | +4.27% | 8.4M |
| 05-12 | $21.73 | $23.73 | +9.20% | 13.2M |
| 05-13 | $22.93 | $23.62 | +3.01% | 11.1M |
| 05-14 | $23.69 | $23.15 | -2.28% | 9.8M |
| 05-15 | $22.59 | $23.32 | +3.23% | 8.6M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.72M | $28.59M | $19.63M | $10.83M |
Operating Income | $704.09M | $-396.36M | $-62.61M | $66.64M |
Net Income | $679.00M | $-443.15M | $-90.54M | $46.91M |
EPS (Diluted) | $2.07 | $-1.69 | $-0.35 | $0.17 |
Total Assets | $9.29B | $6.33B | $5.75B | $6.38B |
Total Liabilities | $7.62B | $5.34B | $4.72B | $5.22B |
Cash & Equivalents | $4.81B | $2.77B | $2.15B | $2.60B |
Free Cash Flow OCF − CapEx | $2.61B | $1.06B | $395.64M | $1.37B |
Shares Outstanding | 329.75M | 262.39M | 255.42M | 270.24M |
No sell-side coverage available for OSCR.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for OSCR.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.